K Number
K052492
Device Name
AIRNERGY+STREAM
Date Cleared
2006-09-05

(358 days)

Product Code
Regulation Number
890.5500
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdparty
Intended Use
The AIRNERGY+® Stream is indicated for use to emit energy to provide topical heating for the purposes of elevating tissue temperature for temporary relief of minor muscle and joint pain, temporary relief of minor arthritis pain and muscle spasm, relieving stiffness, promoting relaxation of muscle tissue, and to temporarily increase local blood circulation where applied.
Device Description
Like the predicate devices the AIRNERGY+® Stream is a lamp that has the same indication for use and equivalent technology. The device electrical and mechanical design is for use and convenience of the users. The red light is generated by LEDs (light emitting diodes) at a wave range between 600 and 650 nm.
More Information

K 022888

K 022888

No
The summary describes a simple LED-based topical heating device and explicitly states "Mentions AI, DNN, or ML: Not Found".

Yes
The device is indicated for therapeutic purposes such as pain relief, relaxation, and increasing blood circulation, which are all therapeutic effects.

No
The device is for therapeutic heating and pain relief, not for diagnosing conditions.

No

The device description explicitly states it is a "lamp" that generates red light using LEDs, indicating it is a hardware device.

Based on the provided information, this device is not an IVD (In Vitro Diagnostic).

Here's why:

  • Intended Use: The intended use clearly describes a device that applies energy to the body for therapeutic purposes (heating tissue, relieving pain, increasing blood circulation). This is a physical therapy or pain management application, not a diagnostic test performed on samples taken from the body.
  • Device Description: The device is described as a lamp emitting red light. This is consistent with a light therapy device, not an IVD which would typically involve reagents, analyzers, or other components for testing biological samples.
  • Lack of IVD Characteristics: There is no mention of analyzing biological samples (blood, urine, tissue, etc.), detecting biomarkers, or providing diagnostic information about a disease or condition.

IVD devices are used to examine specimens derived from the human body to provide information for diagnostic, monitoring, or compatibility purposes. This device does not fit that description.

N/A

Intended Use / Indications for Use

The AIRNERGY+® Stream is indicated for use to emit energy to provide topical heating for the purposes of elevating tissue tem-perature for temporary relief of minor muscle and joint pain, tem-porary relief of minor arthritis pain and muscle spasm, relieving stiffness, promoting relaxation of muscle tissue, and to tempora-rily increase local blood circulation where applied.

Product codes

ILY

Device Description

Like the predicate devices the AIRNERGY+® Stream is a lamp that has the same indication for use and equivalent technology.

The device electrical and mechanical design is for use and convenience of the users. The red light is generated by LEDs (light emitting diodes) at a wave range between 600 and 650 nm.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

Not Found

Indicated Patient Age Range

Not Found

Intended User / Care Setting

Not Found

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

Tests have proven that the AIRNERGY+® is safe and effective with respect to its intended use and does not depict any risk to the user.

The AIRNERGY+® Stream is designed, labeled, and verified for performance and safety. Performance data has proven that it performes safe and effectively with respect to its intended use.

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s)

K 022888

Reference Device(s)

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information

Not Found

§ 890.5500 Infrared lamp.

(a)
Identification. An infrared lamp is a device intended for medical purposes that emits energy at infrared frequencies (approximately 700 nanometers to 50,000 nanometers) to provide topical heating.(b)
Classification. Class II (special controls). The device, when it is an infrared therapeutic heating lamp, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 890.9.

0

K052492

:

.

.

510 (k) Summary of safety and effectiveness
Applicant:natural energy solutions AG
Reisertstraße 21
53773 Hennef, Germany
Phone No.: +49 (22 42) 9330-0
Fax No.: +49 (22 42) 9330-30
E-mail: info@nes-ag.com
SEP - 5 2006
Establishment registration number3004139830
Name of contactDr. Martina Günderoth, MBA
Eisenhutweg 15
84036 Kumhausen-Preisenberg, Germany
Phone No.: ++49 871 430 8378
Fax No.: ++49 871 430 8379
E-mail: mguenderoth@onlinehome.de
Proprietary nameAIRNERGY+®STREAM
Common nameAIRNERGY STREAM
Classification nameInfrared lamp.
Code of Federal Regulations21 CFR 890.5500
Regulatory ClassClass II
Device panel / product codePhysical medicine / ILY
Predicate deviceThere are several infrared lamps known in the market. One of
these is the Acubeam of Light Force Therapy, Inc. (K 022888).
Description of deviceLike the predicate devices the AIRNERGY+® Stream is a lamp
that has the same indication for use and equivalent technology.
510(k) SummaryAIRNERGY+® Stream
The device electrical and mechanical design is for use and
convenience of the users. The red light is generated by LEDs
(light emitting diodes) at a wave range between 600 and 650
nm.
Intended useThe AIRNERGY+® Stream is indicated for use to emit energy to
provide topical heating for the purposes of elevating tissue tem-
perature for temporary relief of minor muscle and joint pain, tem-
porary relief of minor arthritis pain and muscle spasm, relieving
stiffness, promoting relaxation of muscle tissue, and to tempora-
rily increase local blood circulation where applied.
Voluntary standard
compliance- IEC 60601-1
  • IEC 60601-1-2 |
    | | Tests have proven that the AIRNERGY+® is safe and effective
    with respect to its intended use and does not depict any risk to
    the user. |
    | Conclusions | The AIRNERGY+® Stream is designed, labeled, and verified for
    performance and safety. Performance data has proven that it
    performes safe and effectively with respect to its intended use.
    It conforms to applicable ISO standards.
    It has the same indication for use and same technology as the
    predicate devices. |

·

Natural Energy Solutions AG, Hennef/Germany 1.4/0806

:

Page 1 of 2

.

1

652492

.

.

Natural Energy Solutions AG, Hennef/Germany 1.4/0806

.

:

.

:

.

:

:

·

2

Image /page/2/Picture/1 description: The image shows the logo for the Department of Health and Human Services (HHS) in the United States. The logo features a stylized depiction of an eagle with three lines forming its body and head. The eagle is positioned to the right of a circular border containing the text "DEPARTMENT OF HEALTH AND HUMAN SERVICES, USA" in capital letters.

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

Natural Energy Solutions AG % C.R.C. Martina Gunderoth, MBA Regulatory Affairs Manager Eisenhutweg 15 84036 Kumhausen-Preisenberg Germany

SEP - 5 2006

Re: K052492

Trade/Device Name: AIRNERGY+® STREAM Regulation Number: 21 CFR 890.5500 Regulation Name: Infrared lamp Regulatory Class: II Product Code: ILY Dated: June 20, 2006 Received: June 27, 2006

Dear Dr. Gunderoth:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

3

Page 2 - Martina Gunderoth, MBA

This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0115. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.

Sincerely y

Tor
Mark N. Mölke

Mark N. Melkerson Director C Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

4

Indications for Use

510(k) Number (if known): 1